SomaLogic Inc (SomaLogic) is a protein biomarker discovery and clinical diagnostics company. It provides SOMAscan assay, a proteomics technology that compares protein levels in individuals with and without various health conditions and identify biological signals of proteins to develop predictive state tests for disease, health and wellness. The company’s SOMAscan assay is based on its slow off-rate modified aptamer (SOMAmer) reagents that comprise a short single-stranded deoxyribonucleic acid (DNA) sequence consisting of protein-like appendages which enable specific binding to a given protein target. It also offers its SOMAscan technology available to healthcare researchers for conducting clinical protein measurements and biomarker discovery. SomaLogic operates a clinical laboratory and is headquartered in Boulder, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SomaLogic Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- SomaLogic Inc Company Overview
- SomaLogic Inc Company Snapshot
- SomaLogic Inc Pipeline Products and Ongoing Clinical Trials Overview
- SomaLogic Inc - Pipeline Analysis Overview
- SomaLogic Inc - Key Facts
- SomaLogic Inc - Major Products and Services
- SomaLogic Inc Pipeline Products by Development Stage
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
- SomaLogic Inc Pipeline Products Overview
- Next-Generation SOMAscan Assay
- Next-Generation SOMAscan Assay Product Overview
- Protein Chip
- Protein Chip Product Overview
- SOMAscan Assay
- SOMAscan Assay Product Overview
- SOMAscan Assay Clinical Trial
- SomaSignal Test - Acute Kidney Injury
- SomaSignal Test - Acute Kidney Injury Product Overview
- SomaSignal Test - Acute Lung Injury
- SomaSignal Test - Acute Lung Injury Product Overview
- SomaSignal Test - Alzheimer's/Dementia Risk
- SomaSignal Test - Alzheimer's/Dementia Risk Product Overview
- SomaSignal Test - Amyotrophic Lateral Sclerosis
- SomaSignal Test - Amyotrophic Lateral Sclerosis Product Overview
- SomaSignal Test - Anticoagulant Adherence
- SomaSignal Test - Anticoagulant Adherence Product Overview
- SomaSignal Test - Breast Cancer
- SomaSignal Test - Breast Cancer Product Overview
- SomaSignal Test - Cardiovascular Risk
- SomaSignal Test - Cardiovascular Risk Product Overview
- SomaSignal Test - Cardiovascular Risk Clinical Trial
- SomaSignal Test - Cardiovascular Risk W/ Cancer Chemotox
- SomaSignal Test - Cardiovascular Risk W/ Cancer Chemotox Product Overview
- SomaSignal Test - Cardiovascular Risk W/ COVID
- SomaSignal Test - Cardiovascular Risk W/ COVID Product Overview
- SomaSignal Test - CHF Hospitalization Risk
- SomaSignal Test - CHF Hospitalization Risk Product Overview
- SomaSignal Test - CHF Therapy Sensitivity
- SomaSignal Test - CHF Therapy Sensitivity Product Overview
- SomaSignal Test - Childhood Diseases
- SomaSignal Test - Childhood Diseases Product Overview
- SomaSignal Test - Chronic Kidney Disease Prognosis
- SomaSignal Test - Chronic Kidney Disease Prognosis Product Overview
- SomaSignal Test - Colon Cancer
- SomaSignal Test - Colon Cancer Product Overview
- SomaSignal Test - Colorectal Cancer
- SomaSignal Test - Colorectal Cancer Product Overview
- SomaSignal Test - Congestive Heart Failure Prognosis
- SomaSignal Test - Congestive Heart Failure Prognosis Product Overview
- SomaSignal Test - COPD Risk
- SomaSignal Test - COPD Risk Product Overview
- SomaSignal Test - Coronary Artery Disease
- SomaSignal Test - Coronary Artery Disease Product Overview
- SomaSignal Test - Diabetic Retinopathy
- SomaSignal Test - Diabetic Retinopathy Product Overview
- SomaSignal Test - Diabetic Status
- SomaSignal Test - Diabetic Status Product Overview
- SomaSignal Test - Duchenne Muscular Dystrophy
- SomaSignal Test - Duchenne Muscular Dystrophy Product Overview
- SomaSignal Test - Endometrial Cancer
- SomaSignal Test - Endometrial Cancer Product Overview
- SomaSignal Test - Hypertension
- SomaSignal Test - Hypertension Product Overview
- SomaSignal Test - Inflammatory Bowel Disease Susceptibility
- SomaSignal Test - Inflammatory Bowel Disease Susceptibility Product Overview
- SomaSignal Test - Kidney Cancer
- SomaSignal Test - Kidney Cancer Product Overview
- SomaSignal Test - Lung Cancer
- SomaSignal Test - Lung Cancer Product Overview
- SomaSignal Test - Lung Cancer Susceptibility
- SomaSignal Test - Lung Cancer Susceptibility Product Overview
- SomaSignal Test - Lymphoma
- SomaSignal Test - Lymphoma Product Overview
- SomaSignal Test - Melanoma
- SomaSignal Test - Melanoma Product Overview
- SomaSignal Test - Mesothelioma
- SomaSignal Test - Mesothelioma Product Overview
- SomaSignal Test - Multiple Sclerosis
- SomaSignal Test - Multiple Sclerosis Product Overview
- SomaSignal Test - Obesity
- SomaSignal Test - Obesity Product Overview
- SomaSignal Test - Ovarian Cancer
- SomaSignal Test - Ovarian Cancer Product Overview
- SomaSignal Test - Pancreatic Cancer
- SomaSignal Test - Pancreatic Cancer Product Overview
- SomaSignal Test - Parkinson's Disease
- SomaSignal Test - Parkinson's Disease Product Overview
- SomaSignal Test - Peripheral Vascular Function
- SomaSignal Test - Peripheral Vascular Function Product Overview
- SomaSignal Test - Preeclampsia
- SomaSignal Test - Preeclampsia Product Overview
- SomaSignal Test - Preterm Labor
- SomaSignal Test - Preterm Labor Product Overview
- SomaSignal Test - Primary Cardiovascular Risk
- SomaSignal Test - Primary Cardiovascular Risk Product Overview
- SomaSignal Test - Primary Cardiovascular Risk Clinical Trial
- SomaSignal Test - Prostate Cancer
- SomaSignal Test - Prostate Cancer Product Overview
- SomaSignal Test - Pulmonary Function
- SomaSignal Test - Pulmonary Function Product Overview
- SomaSignal Test - Rectal Cancer
- SomaSignal Test - Rectal Cancer Product Overview
- SomaSignal Test - Renal Failure With Cardiovascular Diseases
- SomaSignal Test - Renal Failure With Cardiovascular Diseases Product Overview
- SomaSignal Test - Rheumatoid Arthritis
- SomaSignal Test - Rheumatoid Arthritis Product Overview
- SomaSignal Test - Secondary Cardiovascular Risk
- SomaSignal Test - Secondary Cardiovascular Risk Product Overview
- SomaSignal Test - Sepsis
- SomaSignal Test - Sepsis Product Overview
- SomaSignal Test - Sleep Apnea
- SomaSignal Test - Sleep Apnea Product Overview
- SomaSignal Test - Statin Adherence
- SomaSignal Test - Statin Adherence Product Overview
- SomaSignal Test - Tuberculosis
- SomaSignal Test - Tuberculosis Product Overview
- SomaSignal Test- Liver Fat
- SomaSignal Test- Liver Fat Product Overview
- SomaLogic Inc - Key Competitors
- SomaLogic Inc - Key Employees
- SomaLogic Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- SomaLogic Inc, Recent Developments
- Jan 09, 2023: SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates
- Sep 14, 2022: SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit
- Mar 01, 2022: SomaLogic to Announce Fourth Quarter and Full Year 2021 Financial Results
- Jan 06, 2022: SomaLogic partners with Illumina to develop proteomic solutions
- Nov 01, 2021: SomaLogic announces strategic collaboration with University Hospitals Cleveland Medical Center to treat diabetic patients at high risk of cardiovascular disease
- Aug 02, 2021: SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer
- Jul 09, 2020: Somalogic and NEC Solution Innovators announce launch of Foneslife
- Apr 28, 2020: SomaLogic announces new phase of partnership with NEC Solution Innovators
- Apr 13, 2020: SomaLogic took $2-5 million PPP government loan for COVID-19-struck small businesses, FOIA request shows
- Jan 15, 2020: SomaLogic adds three new SomaSignal tests to its current offerings
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- SomaLogic Inc Pipeline Products and Ongoing Clinical Trials Overview
- SomaLogic Inc Pipeline Products by Equipment Type
- SomaLogic Inc Pipeline Products by Indication
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
- SomaLogic Inc, Key Facts
- SomaLogic Inc, Major Products and Services
- SomaLogic Inc Number of Pipeline Products by Development Stage
- SomaLogic Inc Pipeline Products Summary by Development Stage
- SomaLogic Inc Ongoing Clinical Trials by Trial Status
- SomaLogic Inc Ongoing Clinical Trials Summary
- Next-Generation SOMAscan Assay - Product Status
- Next-Generation SOMAscan Assay - Product Description
- Protein Chip - Product Status
- Protein Chip - Product Description
- SOMAscan Assay - Product Status
- SOMAscan Assay - Product Description
- SOMAscan Assay - Cerebrospinal Fluid-biomarkers-based Diagnostic and Prognostic Models for Multiple Sclerosis
- SOMAscan Assay - Multi-Ethnic Study of Atherosclerosis (MESA)
- SOMAscan Assay - Triangular Phenotyping and Response Assessment in Small Bowel Crohn's Disease Using Magnetic Resonance Enterography (MRE) and Novel Proteomic Biomarkers
- SomaSignal Test - Acute Kidney Injury - Product Status
- SomaSignal Test - Acute Kidney Injury - Product Description
- SomaSignal Test
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alfa Wassermann Diagnostic Technologies, LLC
- Quotient Biodiagnostics Inc
- Life Technologies Corp
- Quotient Biodiagnostics Inc
- ARK Diagnostics Inc
- Targeted Diagnostics & Therapeutics Inc
- Affymetrix, Inc.
- Alfa Wassermann Diagnostic Technologies, LLC
- ARK Diagnostics Inc
